Search Count: 139
All
Selected
 |
Organism: Homo sapiens, Synthetic construct
Method: X-RAY DIFFRACTION Resolution:2.64 Å Release Date: 2025-12-31 Classification: LIGASE Ligands: DMS, AMP |
 |
Dna Ligase 1 E346A/E592A In Complex With Nick Containing 3'-8Oxorg:A Captured At Post-Catalytic Stage
Organism: Homo sapiens, Synthetic construct
Method: X-RAY DIFFRACTION Resolution:1.96 Å Release Date: 2025-12-31 Classification: LIGASE/DNA Ligands: AMP |
 |
Dna Ligase 1 E346A/E592A In Complex With Nick Containing 3'-8Oxorg:C Captured At Pre-Catalytic Stage
Organism: Homo sapiens, Synthetic construct
Method: X-RAY DIFFRACTION Resolution:2.81 Å Release Date: 2025-12-31 Classification: LIGASE/DNA |
 |
Dna Ligase 1 E346A/E592A In Complex With Nick Containing 3'-8Oxodg:A Captured At Pre-Catalytic Stage
Organism: Homo sapiens, Synthetic construct
Method: X-RAY DIFFRACTION Resolution:2.56 Å Release Date: 2025-12-31 Classification: LIGASE/DNA Ligands: DMS |
 |
Dna Ligase 1 E346A/E592A In Complex With Nick Containing 3'-8Oxodg:C Captured At Pre-Catalytic Stage
Organism: Homo sapiens, Synthetic construct
Method: X-RAY DIFFRACTION Resolution:2.96 Å Release Date: 2025-12-31 Classification: LIGASE/DNA |
 |
Dna Ligase 1 Wild-Type In Complex With Nick Containing 3'-8Oxodg:C Captured At Pre-Catalytic Stage
Organism: Homo sapiens, Synthetic construct
Method: X-RAY DIFFRACTION Resolution:2.76 Å Release Date: 2025-12-31 Classification: LIGASE/DNA |
 |
Discovery Of An Orally Bioavailable Reversible Covalent Sars-Cov-2 Mpro Inhibitor With Pan-Coronavirus Activity
Organism: Severe acute respiratory syndrome coronavirus 2, Synthetic construct
Method: X-RAY DIFFRACTION Resolution:1.37 Å Release Date: 2025-08-20 Classification: HYDROLASE/INHIBOTOR Ligands: A1L7M |
 |
Discovery Of An Orally Bioavailable Reversible Covalent Sars-Cov-2 Mpro Inhibitor With Pan-Coronavirus Activity
Organism: Severe acute respiratory syndrome coronavirus 2, Synthetic construct
Method: X-RAY DIFFRACTION Resolution:1.89 Å Release Date: 2025-08-20 Classification: HYDROLASE/INHIBITOR |
 |
Discovery Of An Orally Bioavailable Reversible Covalent Sars-Cov-2 Mpro Inhibitor With Pan-Coronavirus Activity
Organism: Severe acute respiratory syndrome coronavirus 2, Synthetic construct
Method: X-RAY DIFFRACTION Resolution:1.50 Å Release Date: 2025-08-20 Classification: HYDROLASE/INHIBITOR |
 |
Discovery Of An Orally Bioavailable Reversible Covalent Sars-Cov-2 Mpro Inhibitor With Pan-Coronavirus Activity
Organism: Severe acute respiratory syndrome coronavirus 2, Synthetic construct
Method: X-RAY DIFFRACTION Resolution:1.47 Å Release Date: 2025-08-20 Classification: HYDROLASE/INHIBITOR Ligands: A1L7M |
 |
Discovery Of An Orally Bioavailable Reversible Covalent Sars-Cov-2 Mpro Inhibitor With Pan-Coronavirus Activity
Organism: Severe acute respiratory syndrome coronavirus 2, Synthetic construct
Method: X-RAY DIFFRACTION Resolution:2.20 Å Release Date: 2025-08-20 Classification: HYDROLASE/INHIBITOR Ligands: A1L7M |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.76 Å Release Date: 2025-04-16 Classification: DNA BINDING PROTEIN/DNA Ligands: CA |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.74 Å Release Date: 2025-04-16 Classification: DNA BINDING PROTEIN/DNA |
 |
Organism: Escherichia coli
Method: ELECTRON MICROSCOPY Release Date: 2025-02-12 Classification: FLAVOPROTEIN Ligands: FAD, FMN, PO4, K, SF4, SRM |
 |
Organism: Thermochaetoides thermophila
Method: ELECTRON MICROSCOPY Release Date: 2024-11-27 Classification: MEMBRANE PROTEIN Ligands: MG |
 |
Organism: Thermochaetoides thermophila
Method: ELECTRON MICROSCOPY Release Date: 2024-11-27 Classification: MEMBRANE PROTEIN Ligands: LOP, MG |
 |
Organism: Homo sapiens, Synthetic construct
Method: X-RAY DIFFRACTION Resolution:2.69 Å Release Date: 2024-09-25 Classification: LIGASE/DNA Ligands: AMP |
 |
Organism: Homo sapiens, Synthetic construct
Method: X-RAY DIFFRACTION Resolution:2.40 Å Release Date: 2024-09-25 Classification: Ligase/DNA Ligands: AMP |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.91 Å Release Date: 2024-09-04 Classification: ANTIBIOTIC Ligands: MYR, A1AZR |
 |
Organism: Acinetobacter baumannii
Method: X-RAY DIFFRACTION Resolution:2.80 Å Release Date: 2024-09-04 Classification: ANTIBIOTIC Ligands: ANP, MVC, MG, A1AZS |